Skip to main content
Erschienen in: BMC Oral Health 1/2023

Open Access 01.12.2023 | Research

Evaluation of the salivary level of glutathione reductase, catalase and free thiol in patients with oral lichen planus

verfasst von: Fahimeh Rezazadeh, Dorsa Mahdavi, Nima Fassihi, Hossein Sedarat, Elham Tayebi Khorami, Amir Tabesh

Erschienen in: BMC Oral Health | Ausgabe 1/2023

Abstract

Objective

Oral lichen planus (OLP) is a usual chronic inflammatory disease of the oral mucosa with malignant capacity, whose pathogenesis is not yet well known. Free radicals and reactive oxygen species may have a vital role in the pathogenesis of oral lichen planus. This study aimed to assess Glutathione reductase, catalase, and free thiol levels in the saliva of OLP patients and compare it with healthy people.

Methods

In this cross-sectional study, 35 patients with OLP and 20 healthy people were involved. Five mL of whole, unstimulated saliva samples were collected in the morning, and the salivary levels of antioxidants were measured by ELISA technique. In this experiment, sex, age and OLP types were also evaluated.

Results

There was a significant decrease in the patients’ salivary level of Glutathione reductase (0.2043 mU/ml in patients and 0.3901 mU/ml in the control group) and catalase (0.1525 mU/ml in patients and 0.2700 mU/ml in the control group) (p = 0.001). But there were no differences between the two groups regarding free-thiol levels (0.0586 mU/ml in patients and 0.0569 mU/ml in the control group) (p = 0.7). However, there was no correlation between age and gender with the antioxidants’ contents. There was a significant decrease in glutathione reductase and catalase in the erosive type than in the non-erosive type.

Conclusions

In this study, we found that the salivary levels of Glutathione reductase and Catalase were lower in OLP patients than in the healthy group, which means these antioxidants were affected by OLP and also associated with the type of it. So salivary Glutathione reductase and Catalase levels may be used as biomarkers for OLP monitoring and treatment.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Oral Lichen planus (OLP) has been described as a chronic mucocutaneous inflammatory illness, in which oral mucosa is usually involved [1]. It is more predominant in middle-aged women and white patients [1, 2]. The occurrence of OLP is 1–2% in the overall population, while its dominance in the Asian population is 2.6% [3].
Clinical manifestations of OLP include erythema and white lines on the oral mucosa, described as Wickham striae, with various appearances, such as papular, reticular, atrophic, plaque, erosive, and bullous [4, 5]. Erosive or atrophic types of OLP can trigger symptoms varying from a burning sensation to severe pain that influence the patients’ condition of life [4]. The particular etiology of OLP stays uncertain. Collected data verify the participation of cell-mediated immune dysfunction in the progress of OLP [4, 6]. Keratinocyte apoptosis and lymphocytic infiltration have been surveyed to likely stimulate the creation of a cell-mediated immune reaction [7]. Lichen planus is assumed to result from an atypical T-cell-mediated immune reaction in which basal epithelial cells are distinguished as exotic due to alterations in the antigenicity of their cell surface. The reason for this immune-mediated basal cell injury is undiscovered. Also, it is yet undiscovered whether lichen planus characterizes a solitary disease procedure or numerous intently associated entities with related clinical demonstrations [8, 9].
Catalase is an ordinary enzyme discovered in almost all living creatures exposed to oxygen (such as plants, bacteria and animals). It catalyzes the breakdown of hydrogen peroxide into water and oxygen [10]. Hydrogen peroxide is a destructive product of many routine metabolic processes; to avoid damage to cells and tissues, it should be quickly transformed into other, less dangerous materials [11].
Glutathione (GSH) is important in preserving suitable tasks and avoiding oxidative stress in human cells. Furthermore, it acts as the main character in the metabolism and clearance of xenobiotics, performs as a cofactor in confident detoxifying enzymes, contributes to transportation, and regenerates antioxidants such as Vitamins C and E into their reactive forms [12]. The GSR gene in humans encodes the enzyme glutathione reductase (GR), also referred to as glutathione-disulfide reductase (GSR). The conversion of glutathione disulfide (GSSG) to glutathione sulfhydryl form (GSH) is catalyzed by glutathione reductase. The ratio of GSSG/GSH present in the cell is an essential feature in correctly preserving the oxidative equilibrium of the cell; it is substantial that the cell maintains high levels of reduced glutathione and a low level of oxidized glutathione disulfide. This narrow balance is kept by glutathione reductase, which catalyzes the reduction of GSSG to GSH [12].
Apart from the character that disulfides act in protein construction, alterations of reactive cysteine thiols can change the role of proteins and can be included in the modulation of enzymatic activity. Thiols thus function not only in normal cell signaling via S-nitrosation, S-glutathionylation, or S-sulfonation but can also be permanently oxidized by aging and illness and disturb protein tasks [13, 14]. In the existence of oxidants (thiol oxidase), protein thiols can also develop mixed disulfides with glutathione (GSH) [15]. Thiol clusters are essential supporters of the antioxidant team and have been shown to terminate ROS and other free radicals through enzymatic and non-enzymatic methods [16]. Total thiol groups of proteins are primarily responsible for their antioxidant response and may behave as a sensitive marker of oxidative stress [17].
Total thiol groups are highly vulnerable to oxidation and known as one of the most significant plasma sacrificial antioxidants. Once the cells are exposed to oxidative stress, thiol groups are the first antioxidants that are affected. Thiol oxidase is an enzyme that catalyzes the chemical reaction between the reduced type of thiol (free thiol) to the oxidized type of thiol (disulfide form) [17].
The use of saliva as a diagnostic fluid is a moderately topical development. Saliva is a mottled oral fluid arising from major and minor salivary glands. Oral fluid, frequently described as the reflection of the body’s condition, is a precise method to be surveyed for disease and health observation. Saliva is the first line of defense against oxidative stress (OS), the primary source of several systemic and oral illnesses. Significant causes of oral free radicals and reactive oxygen species (ROS) are periodontitis, tobacco smoke and other oral diseases. Saliva contains antioxidants: albumin, ascorbate, uric acid and enzymes that establish the antioxidant capacity of saliva [18].
The inequity in antioxidants is considered crucial in this illness [19, 20]. Increased lipid peroxidation levels, oxidative stress, and serum or salivary oxygen free radicals precede inflammatory procedures and harm the cellular membranes [21]. Reduced antioxidant protection and elevated oxidative stress can play a significant part in the etiology of several diseases, including diabetes [22], Periodontitis [23], Psoriasis [24], Vitiligo [25], and digestive system complaints [20].
Regarding previous studies and since no similar studies evaluated these biological markers, we aimed to determine the salivary levels of catalase, glutathione reductase and thiol oxidate in patients with OLP and the association between these values and the types of disease.

Methods and materials

In this cross-sectional study (during 2019–2020), 35 OLP patients, who were referred to the oral and maxillofacial disease department of the Shiraz dental faculty, were enrolled. Existence of oral lichen planus was confirmed by a specialist based on clinical or histopathologic evaluations. Among those who were referred to Shiraz dental faculty’s oral and maxillofacial disease department, 20 healthy individuals were selected as the control group (age and sex matched). Data, including the severity of the disease (type of OLP), were collected for all patients. The participants were inquired about general health situations, medicine intake and smoking addiction. The exclusion criteria involved the following: other local and systemic inflammatory illnesses, the use of anti-inflammatory drugs and analgesics, the use of vitamin C and E 2 months before the study, smoking, which raises the levels of oxidants, and already being under cure for OLP.
Subjects were requested to restrain from chewing gum, using lipstick, eating or drinking any liquids except water for two hours prior to sampling saliva. They washed their mouth for 30 s with clean water, and the water was eliminated. Subjects were trained not to attempt to produce saliva, talk, or think about foods. Five mL of whole, unstimulated saliva samples were collected in a sterile container and frozen at -20 c until analysis afterward.
Salivary levels of antioxidants were measured by ELISA (Enzyme-Linked Immunosorbent Assay) technique using a Kiazist kit (Kiazist, Iran). Data were analyzed by SPSS version 25.0 (SPSS Inc., IL, USA), applying mean ± SD and frequency (%). Independent t-test and chi-square were used to compare all data, such as age, sex, and types of lichen planus, between groups. A repeated measure ANOVA (RM-ANOVA) was used to assess the changes in some measurements during times. P < 0.05 was significant.

Result

In this study, 35 OLP patients, including fifteen males and twenty females, and 20 healthy individuals, including nine males and eleven females, were examined. With regard to the Chi-square test, both groups were similar in sex distribution (p = 0.87). The mean age of patients was 33.46 ± 13.41, and the mean age of healthy people was 31.85 ± 5.98; thus, there was no significant difference between the mean ages of the two groups (p = 0.54).
Based on clinical examinations, among the OLP patients, we had 13 with the erosive type (37.1%), and 22 with the non-erosive type (62.9%).
Statistical data analyses clarified that the mean Glutathione reductase was 0.2043(± 0.1769) mU/ml in OLP patients and 0.3901 (± 0.1060) mU/ml in the control group. The mean saliva level of catalase was 0.1525 (± 0.0618) mU/ml in OLP patients and 0.2700 (± 0.0563) mU/ml in the control group. The salivary level of free thiol was 0.0586 (± 0.0162) mU/ml in OLP patients and 0.0569 (± 0.0155) mU/ml in the control group.
According to Independent T-test, there was a significant decrease in Glutathione reductase and catalase in the OLP group (p = 0.001) and there were no differences in free-thiol between the two groups (p = 0.7).
Based on the One-Way ANOVA test, there was no association between Glutathione reductase, Ctalase, and Free thiol concerning age and sex. The main difference between the two groups was the distinct levels of Glutathione reductase and Catalase (Table 1). There was a significant decrease in glutathione reductase and catalase in the erosive group (Table 2).
Table 1
Comparison of group, age and sex in different antioxidants
 
P-value
Glutathion reductase
Group
Age
Sex
0.002
0.255
0.408
Catalase
Group
Age
Sex
0.000
0.542
0.562
Free thiol
Group
Age
Sex
0.505
0.301
0.251
Table 2
Comparison of different antioxidants in erosive and non-erosive group
 
Type
Number
Mean
St.Deviation
P-value
glutathion_reductase
(mU/ml)
erosive
Non-erosive
13
22
0.9369
0.2696
0.1849
0.7416
0.000
Catalase
(mU/ml)
erosive
Non-erosive
13
22
0.1023
0.1822
0.1374
0.5999
0.000
free_thiol
(mU/ml)
erosive
Non-erosive
13
22
0.5540
0.6053
0.1496
0.1704
0.375

Discussion

At present, it has been declared that the difference in stages of free radicals and ROS with antioxidants can play a significant part in the onset of numerous inflammatory illnesses [26].
In this research, the relationship between the mean salivary level of some antioxidants (Glutathione reductase, Catalase and Free thiol) and OLP was analyzed. Based on the present results, there was a significant reduction in glutathione reductase and catalase salivary levels in OLP patients compared to healthy participants due to the type of OLP. However, various researchers assessed other antioxidants level in OLP patients, and we compared them with our study. In accordance with the present study, Sedigheh Bakhtiari et al. manifested OLP was correlated with a reduction in Uric Acid (UA) stages in the saliva. They presented salivary UA as a biomarker that could be utilized for observing and treating OLP [27].
Corroborating the findings of our study, Tugba Tunali-Akbay et al. demonstrated that total antioxidant capacity (TAC) and GSH accumulation were lower in patients with OLP [28]. In addition to our results, Daniela Miricescu et al. illustrated that OS reduced the antioxidant levels in the oral cavity. Uric acid, albumin and TAC are significant and hopeful salivary biomarkers for checking the oral OS. Salivary TAC actions were significantly lower in periodontitis, OLP and smoker patients than in the control groups, indicating an essential oxidative procedure in the oral cavity [18].
Shirzaiy M et al. concluded that levels of Gluthatione peroxidase and superoxide dismutase were remarkably lower in OLP patients compared healthy people [29].
In another study, Sezer E et al. found significantly lower erythrocyte catalase levels in a group of patients with OLP [30].
Atena shiva et al. clarified that OLP groups have more significant cellular lipid peroxidation compared to healthy controls and low stage of (total antioxidant activity) TAA than controls. Patients with OLP are assumed to be further in danger of antioxidant-oxidative stress inequality [31].
In contrast to this study, Suma et al. explained in their examination of the saliva of brain tumor patients that salivary protein thiols were significantly increased [32]. While the patients’ conditions were different than ours, perhaps with the reduction of free thiol in the reduced form of intracellular glutathione, there was another compensating pathway with a different form of extracellular free thiol protein, and the final measurable free thiol remained constant in our results.
Goes Gonzaga et al. found that level of GSH in OLP patients was not remarkably different in comparison with healthy people. However, despite of conducted researches on the effectiveness of oxidative stress markers of saliva in OLP patients, he proposed a better standardization of methods for more accurate conclusion [33].
According to our study, age and gender are not associated with antioxidants level. So the level of antioxidants is not affected by the age and gender of the patients.
Similar to these findings, Rezazadeh et al. showed no significant connection between the level of salivary IL-10 and sex and age in oral lichen planus [34].
As we realized in this research, glutathione reductase and catalase significantly declined in the erosive type of OLP compared to the non-erosive type. Azizi et al. also displayed that salivary and plasma stages of total antioxidant grade in erosive OLP patients were lower than in the healthy participants [35].
The limitation of this study was detecting an approved laboratory to achieve reliable saliva test results. Different labs and several kits were estimated, and the reliability and validity of the one used in our study were verified. Another limitation of this study was the small size of the sample.

Conclusion

Present results showed a significant decrease in Glutathione reductase and Catalase salivary levels in OLP patients compared to the control group. There was also a correlation between the type of OLP and antioxidant levels; Glutathione reductase and Catalase salivary levels were lower in erosive than non-erosive type; we also found no correlation between age and gender with these antioxidant contents. Our findings show these antioxidants were affected by OLP and also related to its type. Hence, salivary Glutathione reductase and Catalase levels may be used as biomarkers for OLP monitoring and treatment.

Acknowledgements

The authors thank the Vice-Chancellor of Shiraz University of Medical Science for supporting this research. This manuscript is based on the thesis written by Dorsa Mahdavi. The authors would also like to thank Dental Research Development Center for help with the statistical analysis.

Declarations

All stages of the investigation were conducted in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the ethical committee of the Shiraz University of Medical Sciences (number = IR.SUMS.DENTAL.REC.1398.107). Ethical considerations were considered during each step of the research process Informed consent was obtained from all individual participants included in the study. The patients’ identity was kept anonymous for all members of the research team.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Payeras MRCK, Figueiredo MA, Salum FG. Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol. 2013;58:1057–69.CrossRefPubMed Payeras MRCK, Figueiredo MA, Salum FG. Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol. 2013;58:1057–69.CrossRefPubMed
2.
Zurück zum Zitat Fahimeh R, Mahshid S. Plasma level of trace elements in patients with oral lichen planus. Iran J Dermatology. 2018;21(2):54–8. Fahimeh R, Mahshid S. Plasma level of trace elements in patients with oral lichen planus. Iran J Dermatology. 2018;21(2):54–8.
3.
Zurück zum Zitat Demographic. Clinical profile of oral lichen planus: a retrospective study. Contemp Clin Dent. 2013;4:181–5.CrossRef Demographic. Clinical profile of oral lichen planus: a retrospective study. Contemp Clin Dent. 2013;4:181–5.CrossRef
4.
Zurück zum Zitat Gupta SJM. Oral lichen planus: an update on etiology, pathogenesis, clinical presentation, diagnosis and management. Indian J dermatology. 2015;60(3):222.CrossRef Gupta SJM. Oral lichen planus: an update on etiology, pathogenesis, clinical presentation, diagnosis and management. Indian J dermatology. 2015;60(3):222.CrossRef
5.
Zurück zum Zitat Scully CCM. Oral mucosal disease: Lichen planus. Br J Oral Maxillofac Surg. 2008;46(1):15–21.CrossRefPubMed Scully CCM. Oral mucosal disease: Lichen planus. Br J Oral Maxillofac Surg. 2008;46(1):15–21.CrossRefPubMed
6.
Zurück zum Zitat Rezazadeh F, Beirami M, Zareshahrabadi Z, Sedarat H, Zomorodian K. Evaluation of the Distribution of Candida Species in Patients with Dysplastic and Nondysplastic Oral Lichen Planus Lesions. BioMed research international. 2022;2022. Rezazadeh F, Beirami M, Zareshahrabadi Z, Sedarat H, Zomorodian K. Evaluation of the Distribution of Candida Species in Patients with Dysplastic and Nondysplastic Oral Lichen Planus Lesions. BioMed research international. 2022;2022.
7.
Zurück zum Zitat Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand. 2001;59(3):174–7.CrossRefPubMed Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand. 2001;59(3):174–7.CrossRefPubMed
8.
Zurück zum Zitat Edwards PC, Kelsch R. Oral lichen planus: clinical presentation and management. J Can Dent Assoc. 2002;68(8):494–9.PubMed Edwards PC, Kelsch R. Oral lichen planus: clinical presentation and management. J Can Dent Assoc. 2002;68(8):494–9.PubMed
9.
Zurück zum Zitat Rezazadeh F, Haghighat S. Serum Vitamin Profile in Oral Lichen Planus Patients in Southwest of Iran. BioMed research international. 2021;2021. Rezazadeh F, Haghighat S. Serum Vitamin Profile in Oral Lichen Planus Patients in Southwest of Iran. BioMed research international. 2021;2021.
10.
Zurück zum Zitat Chelikani PFI, Loewen PC. Diversity of structures and properties among catalases”. Cellular and Molecular Life Sciences. January 2004. Chelikani PFI, Loewen PC. Diversity of structures and properties among catalases”. Cellular and Molecular Life Sciences. January 2004.
11.
Zurück zum Zitat Gaetani GF, Ferraris A, Rolfo M, Mangerini R, Arena S, Kirkman H. Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. 1996. Gaetani GF, Ferraris A, Rolfo M, Mangerini R, Arena S, Kirkman H. Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. 1996.
12.
Zurück zum Zitat D. M. “Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes”. Biochim Biophys Acta (May 2013).(1830 (5): 3217–66). D. M. “Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes”. Biochim Biophys Acta (May 2013).(1830 (5): 3217–66).
13.
Zurück zum Zitat Mallis RJHM, Zhao W, Zhang T, Hendrich S, Thomas JA. Irreversible thiol oxidation in carbonic anhydrase III: protection by S-glutathiolation and detection in aging rats. Biol Chem. 2002;383:649–62.CrossRefPubMed Mallis RJHM, Zhao W, Zhang T, Hendrich S, Thomas JA. Irreversible thiol oxidation in carbonic anhydrase III: protection by S-glutathiolation and detection in aging rats. Biol Chem. 2002;383:649–62.CrossRefPubMed
14.
Zurück zum Zitat Adachi TWR, Pimentel DR, Ying J, Sharov VS, Schoneich C, Cohen RA. SGlutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med. 2004(;10:1200–7. Adachi TWR, Pimentel DR, Ying J, Sharov VS, Schoneich C, Cohen RA. SGlutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med. 2004(;10:1200–7.
15.
Zurück zum Zitat 15, Kim YH JR, Kwon KS, Lee SR, Rhee SG. Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal Biochem. 2000;283:214–21. 15, Kim YH JR, Kwon KS, Lee SR, Rhee SG. Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal Biochem. 2000;283:214–21.
16.
Zurück zum Zitat Jones DPCJ, MV et al. Redox state of glutathione in human plasma. Free RadicBiol Med (2000; 28: 625 – 35.). Jones DPCJ, MV et al. Redox state of glutathione in human plasma. Free RadicBiol Med (2000; 28: 625 – 35.).
17.
Zurück zum Zitat GJ HB. The antioxidants of human extracellular fluids. Arch Biochem Biophys. (1990; 280: 1–8.). couple. Free Radic Biol Med. (2001; 30: 1191 – 212.). GJ HB. The antioxidants of human extracellular fluids. Arch Biochem Biophys. (1990; 280: 1–8.). couple. Free Radic Biol Med. (2001; 30: 1191 – 212.).
18.
Zurück zum Zitat Daniela Miricesc MG, Alexandra Totan A, Didilescu R, Rădulescu. THE ANTIOXIDANT POTENTIAL OF SALIVA: CLINICAL SIGNIFICANCE IN ORAL DISEASES Department of Biochemistry, Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. Daniela Miricesc MG, Alexandra Totan A, Didilescu R, Rădulescu. THE ANTIOXIDANT POTENTIAL OF SALIVA: CLINICAL SIGNIFICANCE IN ORAL DISEASES Department of Biochemistry, Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
19.
Zurück zum Zitat Aly DGSR. Oxidative stress in lichen planus. Panonica, et Adriatica: Acta dermatovenerologica Alpina; 2010. Aly DGSR. Oxidative stress in lichen planus. Panonica, et Adriatica: Acta dermatovenerologica Alpina; 2010.
20.
Zurück zum Zitat Rajentheran RMN, Kelly CG, Reed MF, Nolan A. Malignant transformation of oral lichen planus. European Journal of Surgical Oncology. Rajentheran RMN, Kelly CG, Reed MF, Nolan A. Malignant transformation of oral lichen planus. European Journal of Surgical Oncology.
21.
Zurück zum Zitat Rezaie APR, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause. Dig Dis Sci. 2007. Rezaie APR, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause. Dig Dis Sci. 2007.
22.
Zurück zum Zitat Rahimi RNS, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine & Pharmacotherapy; 2005. Rahimi RNS, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine & Pharmacotherapy; 2005.
23.
Zurück zum Zitat Mashayekhi FAF, Rezaie A, Zamani MJ, Khorasani R, Abdollahi M. Alteration of cyclic nucleotides levels and oxidative stress in saliva of human subjects with periodontitis. J Contemp Dent Pract. 2005. Mashayekhi FAF, Rezaie A, Zamani MJ, Khorasani R, Abdollahi M. Alteration of cyclic nucleotides levels and oxidative stress in saliva of human subjects with periodontitis. J Contemp Dent Pract. 2005.
24.
Zurück zum Zitat Relhan VGS, Dayal S, Pandey R, Lal H. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol. 2002. Relhan VGS, Dayal S, Pandey R, Lal H. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol. 2002.
25.
Zurück zum Zitat Yildirim MBV, Inaloz HS, Kesici D, Delibas N. The role of oxidants and antioxidants in generalized vitiligo. J Dermatol. 2003. Yildirim MBV, Inaloz HS, Kesici D, Delibas N. The role of oxidants and antioxidants in generalized vitiligo. J Dermatol. 2003.
26.
27.
Zurück zum Zitat Bakhshi SBaPTbSSaM. Assessment of Uric Acid Level in the saliva of patients with oral Lichen Planus September 29, 2016. Bakhshi SBaPTbSSaM. Assessment of Uric Acid Level in the saliva of patients with oral Lichen Planus September 29, 2016.
28.
Zurück zum Zitat Tunali-Akbay T, Solmaz Z, Pekiner FN, İpekci H. Salivary tissue factor concentration and activity in patients with oral lichen planus. Oral Sci Int. 2017;14(1):13–7.CrossRef Tunali-Akbay T, Solmaz Z, Pekiner FN, İpekci H. Salivary tissue factor concentration and activity in patients with oral lichen planus. Oral Sci Int. 2017;14(1):13–7.CrossRef
31.
Zurück zum Zitat Arab ASS. Evaluation of uric acid, total antioxidant and lipid peroxidation parameters in serum and saliva of patients with oral Lichen Planus.: April 5, 2016. Arab ASS. Evaluation of uric acid, total antioxidant and lipid peroxidation parameters in serum and saliva of patients with oral Lichen Planus.: April 5, 2016.
32.
Zurück zum Zitat Suma H, Prabhu K, Shenoy RP, Annaswamy R, Rao S, Rao A. Estimation of salivary protein thiols and total antioxidant power of saliva in brain tumor patients. J Cancer Res Ther. 2010;6(3):278.CrossRefPubMed Suma H, Prabhu K, Shenoy RP, Annaswamy R, Rao S, Rao A. Estimation of salivary protein thiols and total antioxidant power of saliva in brain tumor patients. J Cancer Res Ther. 2010;6(3):278.CrossRefPubMed
34.
Zurück zum Zitat Rezazadeh F, Shahbazi F, Andisheh-Tadbir A. Evaluation of salivary level of IL-10 in patients with oral lichen planus, a preliminary investigation. Comp Clin Pathol. 2017;26(3):531–4.CrossRef Rezazadeh F, Shahbazi F, Andisheh-Tadbir A. Evaluation of salivary level of IL-10 in patients with oral lichen planus, a preliminary investigation. Comp Clin Pathol. 2017;26(3):531–4.CrossRef
35.
Zurück zum Zitat Azizi A, Farshchi F. Comparison of salivary and plasma antioxidant levels in lichen planus patients and healthy subjects. J oral Pathol Med. 2012;41(7):524–6.CrossRefPubMed Azizi A, Farshchi F. Comparison of salivary and plasma antioxidant levels in lichen planus patients and healthy subjects. J oral Pathol Med. 2012;41(7):524–6.CrossRefPubMed
Metadaten
Titel
Evaluation of the salivary level of glutathione reductase, catalase and free thiol in patients with oral lichen planus
verfasst von
Fahimeh Rezazadeh
Dorsa Mahdavi
Nima Fassihi
Hossein Sedarat
Elham Tayebi Khorami
Amir Tabesh
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Oral Health / Ausgabe 1/2023
Elektronische ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03242-1

Weitere Artikel der Ausgabe 1/2023

BMC Oral Health 1/2023 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.